세계의 생검 가이던스 시스템 시장 : 제품, 용도, 최종 용도별 예측(2025-2030년)

The Biopsy Guidance System Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.54 billion in 2024, and is projected to grow at a CAGR of 7.34%, to USD 2.38 billion by 2030.

The biopsy guidance system market encompasses technologies and devices designed to improve the accuracy, safety, and efficiency of obtaining tissue samples for diagnostic purposes. These systems are crucial for detecting anomalies such as cancer, offering precise targeting and minimizing invasiveness. The necessity is underscored by the rising prevalence of cancer and other chronic diseases requiring accurate diagnostics, prompting healthcare facilities to adopt advanced guidance systems. Applications range from ultrasound, CT, MRI-guided biopsies to stereotactic and robotic-assisted procedures. End-users primarily include hospitals, diagnostic centers, and specialty clinics. Key factors influencing market growth include technological advancements in imaging, growing demand for minimally invasive procedures, and increasing awareness among healthcare professionals. However, challenges such as high equipment costs, regulatory hurdles, limited skilled personnel, and issues related to device standardization may impede growth. Opportunities abound in emerging markets with expanding healthcare infrastructure and increased government funding for cancer research. Companies can capitalize on these by investing in R&D to innovate cost-effective, portable, and user-friendly systems, expanding product portfolios through strategic collaborations, and focusing on training programs to enhance usability and adoption. In terms of limitations, the potential for adverse effects during procedures, coupled with stringent regulatory compliance requirements, pose significant barriers. Areas ripe for innovation include the development of AI-integrated systems for real-time image analysis, improved wireless communication between devices for enhanced accuracy, and the use of biodegradable materials for one-time use instruments. The market is dynamic with rapid technological evolution, yet it demands careful navigation through regulatory landscapes and persistent innovation to maintain competitive advantage. Businesses that prioritize understanding these landscapes and actively pursue strategic partnerships and technological advancements are best positioned to secure sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopsy Guidance System Market

The Biopsy Guidance System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of cancer and chronic diseases requiring diagnostic procedures
  • Increasing preference for minimally invasive biopsy treatments
  • Government campaigns and initiatives for early disease diagnosis
• Market Restraints
  • Need for specialized training and inaccuracy of biopsy systems
• Market Opportunities
  • Technological advancements in biopsy guidance systems
  • Favorable reimbursement policies for biopsy procedures
• Market Challenges
  • Technical complexities associated with biopsy guidance system

Porter's Five Forces: A Strategic Tool for Navigating the Biopsy Guidance System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopsy Guidance System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopsy Guidance System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopsy Guidance System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopsy Guidance System Market

A detailed market share analysis in the Biopsy Guidance System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopsy Guidance System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopsy Guidance System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopsy Guidance System Market

A strategic analysis of the Biopsy Guidance System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Guidance System Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biobot Surgical Pte Ltd., Body Vision Medical Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IMS Giotto S.p.A, Inomed Health Limited, INRAD Inc., IZI Medical Products, KOELIS, Koninklijke Philips N.V., KPI Healthcare India pvt Ltd, Mauna Kea Technologies, Medtronic PLC, Merit Medical Systems, NeoDynamics AB, Olympus Corporation, Planmed Oy, Siemens Healthineers AG, STERYLAB S.r.l., Stryker Corporation, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Biopsy Guidance System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across MRI Guided Biopsy, Stereotactic Guided Biopsy, and Ultrasound Guided Biopsy.
• Based on Application, market is studied across Brain Biopsy, Breast Biopsy, Lungs, and Prostate.
• Based on End-Use, market is studied across Diagnostic Centers, Hospitals, Research & Academic Institutes, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of cancer and chronic diseases requiring diagnostic procedures
    • 5.1.1.2. Increasing preference for minimally invasive biopsy treatments
    • 5.1.1.3. Government campaigns and initiatives for early disease diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. Need for specialized training and inaccuracy of biopsy systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in biopsy guidance systems
    • 5.1.3.2. Favorable reimbursement policies for biopsy procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Technical complexities associated with biopsy guidance system
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities
  • 5.2.2. Application: Improved applications for breast biopsies for enhanced accuracy
  • 5.2.3. End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopsy Guidance System Market, by Product

• 6.1. Introduction
• 6.2. MRI Guided Biopsy
• 6.3. Stereotactic Guided Biopsy
• 6.4. Ultrasound Guided Biopsy

7. Biopsy Guidance System Market, by Application

• 7.1. Introduction
• 7.2. Brain Biopsy
• 7.3. Breast Biopsy
• 7.4. Lungs
• 7.5. Prostate

8. Biopsy Guidance System Market, by End-Use

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals
• 8.4. Research & Academic Institutes
• 8.5. Specialty Clinics

9. Americas Biopsy Guidance System Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biopsy Guidance System Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biopsy Guidance System Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. FDA Clears MRI-Compatible Robotics System for Breast Biopsy
  • 12.3.2. Stryker Launches Q Guidance with Cranial Guidance Software
  • 12.3.3. GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argon Medical Devices, Inc.
• 2. Becton, Dickinson and Company
• 3. Bio-Rad Laboratories, Inc.
• 4. Biobot Surgical Pte Ltd.
• 5. Body Vision Medical Ltd.
• 6. Boston Scientific Corporation
• 7. Cardinal Health, Inc.
• 8. Cook Group Incorporated
• 9. Danaher Corporation
• 10. Fujifilm Holdings Corporation
• 11. GE Healthcare
• 12. Hologic, Inc.
• 13. IMS Giotto S.p.A
• 14. Inomed Health Limited
• 15. INRAD Inc.
• 16. IZI Medical Products
• 17. KOELIS
• 18. Koninklijke Philips N.V.
• 19. KPI Healthcare India pvt Ltd
• 20. Mauna Kea Technologies
• 21. Medtronic PLC
• 22. Merit Medical Systems
• 23. NeoDynamics AB
• 24. Olympus Corporation
• 25. Planmed Oy
• 26. Siemens Healthineers AG
• 27. STERYLAB S.r.l.
• 28. Stryker Corporation
• 29. Trivitron Healthcare